It began with a small, two-room clinic in downtown Memphis, Tennessee. William H. West, MD, was a nationally respected oncologist and lead investigator for the National Institutes of Health in Washington, D.C. Following the loss of his mother to breast cancer, his mission became clear: to provide world-class cancer treatment and research capabilities in his... Read more »
West Cancer Center and Saint Francis Healthcare Announce Joint Relationship New affiliation includes first-in-the-Mid-South cancer urgent care center West Cancer Center and Research Institute and Saint Francis Healthcare today announced an agreement to advance and increase access to cancer care in the Mid-South. This collaboration is supported by multi-million dollar investments in cancer… Read more »
West Fight On returns to Shelby Farms Park on September 11, 2021 Get ready to cycle, run, or walk to beat cancer! West Fight On benefiting West Cancer Foundation will be LIVE and IN-PERSON this September! This signature fundraising event will return to its home at Shelby Farms Park on Saturday, September 11,… Read more »
Patients and Family We understand how overwhelming a cancer diagnosis can be. Our physicians and staff are here to help you and your loved ones navigate through your entire cancer journey, CareSpace Patient Portal Patient Stories New Patient Handbook Insurance Information What We Treat What Is Cancer? Pay Bill Care Support Services Advance Directive &... Read more »
Here at West Cancer Center & Research Institute, we are proud to host our own virtual tumor boards, or Multidisciplinary Conferences, multiple times each week. In these multidisciplinary conferences, we bring together a variety of providers from different disciplines and even institutions to talk about patient cases. It is in these conferences that a group… Read more »
Dr. Daniel Vaena, Director of Experimental Therapeutics Program at West Cancer Center Research Institute, co-presented updated data from Compugen Ltd.’s Phase 1 dose escalation and expansion study of COM701 as a monotherapy, and in a dose escalation combination study with Opdivo® (nivolumab) Vaena states “Although these results are very preliminary, they suggest that targeting… Read more »
It is with great excitement that our West Cancer Center and Research Institute network adds a new leadership role to our Division of Pharmacy. Camille Hill, PharmD has recently accepted a newly created role of Vice President of Oncology Pharmacy Services, which has become a vital aspect for our network as West continues to grow…. Read more »
Click here to view this full article on OncLive.com. The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »
Oral Abstract Session: Melanoma/Skin Cancers Sunday, June 6, 2021; 8:00 AM–11:00 AM EDT 9501 Final analysis of overall survival (OS) and relapse-free-survival (RFS) in the intergroup S1404 phase III randomized trial comparing either high-dose interferon (HDI) or ipilimumab to pembrolizumab in patients with high-risk resected melanoma. KF Grossmann, M Othus, SP Patel, et al Take-Home Message The… Read more »
West Cancer Center Palliative Care Physician, Dr. W. Clay Jackson, recently co-authored a case report alongside fellow, Jessica Rich, DO, published in Consultant 360. The two detail a patient case regarding pain in a man with opioid-use-disorder who is taking medication assisted therapy. Pain in a Man With Opioid Use Disorder Who Is Taking… Read more »
